Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Eukaryotic Gene Expression
Factor de Impacto: 2.156 Factor de Impacto de 5 años: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Imprimir: 1045-4403
ISSN En Línea: 2162-6502

Volumes:
Volumen 30, 2020 Volumen 29, 2019 Volumen 28, 2018 Volumen 27, 2017 Volumen 26, 2016 Volumen 25, 2015 Volumen 24, 2014 Volumen 23, 2013 Volumen 22, 2012 Volumen 21, 2011 Volumen 20, 2010 Volumen 19, 2009 Volumen 18, 2008 Volumen 17, 2007 Volumen 16, 2006 Volumen 15, 2005 Volumen 14, 2004 Volumen 13, 2003 Volumen 12, 2002 Volumen 11, 2001 Volumen 10, 2000 Volumen 9, 1999 Volumen 8, 1998 Volumen 7, 1997 Volumen 6, 1996 Volumen 5, 1995 Volumen 4, 1994

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2017019467
pages 79-90

Acute HIV Infection: Advances in Mechanisms and Prophylactic Therapeutic Management

Muhammad Imran Qadir
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan
Amman Abid
Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan

SINOPSIS

Human infection by HIV is spreading rapidly. The spread of the virus is generally organized and transmission can be rectal, oral, or penile. Several types of cells are susceptible to viral invasion. The appearance of symptoms during infection can vary, but the presence of the virus can be confirmed by testing for the antigen p24. The ELISA test is used to detect viral p24 antigen and antiviral antibodies. This technique is approved for the purposes of clinical practice. Highly active antiretroviral therapy is usually a costly and lengthy treatment for HIV infection. A rapid point of care test has also been developed to detect acute infection. There is a need for preventing HIV infection and improving antiretroviral therapy. The treatment regime currently constitutes drugs that have the capability to concentrate in the genital tract of both males and females, as well as the use of integrase inhibitors that rapidly reduce viral load.


Articles with similar content:

Immune Responses Against Persistent Viral Infections: Possible Avenues for Immunotherapeutic Interventions
Critical Reviews™ in Immunology, Vol.28, 2008, issue 2
Edward J. Usherwood, Michael J. Molloy, Shinichiro Fuse
TSG101: Tumor Susceptibility Gene 101 (tsg101) Product−Role in Therapy Against HIV/AIDS
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 3
Maria Zafar, Muhammad Imran Qadir
New Technologies in Using Recombinant Attenuated Salmonella Vaccine Vectors
Critical Reviews™ in Immunology, Vol.30, 2010, issue 3
Yuhua Li, Bronwyn Gunn, Soo-Young Wanda, Wei Kong, Wei Xin, Shifeng Wang, Roy Curtiss III
Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 6
Sanaul Mustafa, Roopa S Pai, Gurinder Singh
Device-Related Infections: A Review
Journal of Long-Term Effects of Medical Implants, Vol.15, 2005, issue 5
John M. Embil, Donald C. Vinh